These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7524800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Emergence and mechanisms of bacterial resistance in surgical infections.
    Neu HC.
    Am J Surg; 1995 May; 169(5A Suppl):13S-20S. PubMed ID: 7755162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors.
    Maddux MS.
    Pharmacotherapy; 1991 May; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831
    [Abstract] [Full Text] [Related]

  • 7. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 May; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial resistance in gram-positive bacteria.
    Rice LB.
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [Abstract] [Full Text] [Related]

  • 11. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M.
    Pharmacotherapy; 1995 Jun; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Jun; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    Obi CL, Makandiramba B, Robertson V, Tswana SA, Moyo SR, Nziramasanga P.
    East Afr Med J; 1998 Mar; 75(3):162-5. PubMed ID: 9640815
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control].
    Dolapçi I.
    Mikrobiyol Bul; 2005 Apr; 39(2):229-40. PubMed ID: 16128036
    [Abstract] [Full Text] [Related]

  • 19. Parenteral beta-lactamase inhibitor combinations for clinical use.
    Manzella JP.
    Am Fam Physician; 1995 May 15; 51(7):1695-8. PubMed ID: 7754928
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.